Trends in hepatocellular carcinoma research from 2008 to 2017: a bibliometric analysis

Objectives To comprehensively analyse the global scientific outputs of hepatocellular carcinoma (HCC) research. Methods Data of publications were downloaded from the Web of Science Core Collection. We used CiteSpace IV and Excel 2016 to analyse literature information, including journals, countries/regions, institutes, authors, citation reports and research frontiers. Results Until March 31, 2018, a total of 24,331 papers in HCC research were identified as published between 2008 and 2017. Oncotarget published the most papers. China contributed the most publications and the United States occupied leading positions in H-index value and the number of ESI top papers. Llovet JM owned the highest co-citations. The keyword “transarterial chemoembolization” ranked first in the research front-line. Conclusions The amount of papers published in HCC research has kept increasing since 2008. China showed vast progress in HCC research, but the United States was still the dominant country. Transarterial chemoembolization, epithelial-mesenchymal transition, and cancer stem cell were the latest research frontiers and should be paid more attention.

[1]  Hien Dang,et al.  Single‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma , 2018, Hepatology.

[2]  G. Berx,et al.  Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity. , 2017, Trends in genetics : TIG.

[3]  Y. N. Park,et al.  Hepatocellular Carcinomas Expressing ‘Stemness'-Related Markers: Clinicopathological Characteristics , 2014, Digestive Diseases.

[4]  M. Petz,et al.  Epithelial-mesenchymal transition in hepatocellular carcinoma. , 2009, Future oncology.

[5]  J. Tseng,et al.  Underutilization of therapy for hepatocellular carcinoma in the medicare population , 2011, Cancer.

[6]  H. El‐Serag,et al.  Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.

[7]  Sahil Mittal,et al.  Epidemiology of hepatocellular carcinoma: consider the population. , 2013, Journal of clinical gastroenterology.

[8]  S. Azer The Top-Cited Articles in Medical Education: A Bibliometric Analysis , 2015, Academic medicine : journal of the Association of American Medical Colleges.

[9]  H. Romdhane,et al.  Gender difference in patients with hepatocellular carcinoma. , 2013, La Tunisie medicale.

[10]  Johan A. Wallin,et al.  The bibliometric analysis of scholarly production: How great is the impact? , 2015, Scientometrics.

[11]  E. Garfield The history and meaning of the journal impact factor. , 2006, JAMA.

[12]  J J Fung,et al.  Liver Transplantation in the United States, 1999–2008 , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  O. Ogunwobi,et al.  Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma , 2018 .

[14]  C. Heeschen,et al.  Standing out from the crowd: cancer stem cells in hepatocellular carcinoma. , 2013, Cancer cell.

[15]  Q. Gao,et al.  Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma. , 2017, Hepatobiliary surgery and nutrition.

[16]  J. Hu,et al.  Surface markers of hepatocellular cancer stem cells and their clinical potential. , 2014, Neoplasma.

[17]  Guillermo J. Lagos-Grisales,et al.  Mitigation of the global impact of Lassa fever: Have we investigated enough about this Arenavirus? - A bibliometric analysis of Lassa Fever research. , 2018, Travel medicine and infectious disease.

[18]  P. Kalakoti,et al.  An Analysis of Publication Productivity During Residency for 1506 Neurosurgical Residents and 117 Residency Departments in North America , 2018, Neurosurgery.

[19]  P. Terasaki,et al.  Liver transplantation in the United States. , 2005, Clinical transplants.

[20]  Juan Enrique Ramos,et al.  Using TF-IDF to Determine Word Relevance in Document Queries , 2003 .

[21]  Derek Y. Chiang,et al.  Pivotal role of mTOR signaling in hepatocellular carcinoma. , 2008, Gastroenterology.

[22]  D. Groneberg,et al.  Ovarian cancer: density equalizing mapping of the global research architecture , 2017, International Journal of Health Geographics.

[23]  Chaomei Chen,et al.  Searching for intellectual turning points: Progressive knowledge domain visualization , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. El‐Serag,et al.  Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. , 2017, Gastroenterology.

[25]  G. Barrière,et al.  Epithelial Mesenchymal Transition: a double-edged sword , 2015, Clinical and Translational Medicine.

[26]  A. Pritchard,et al.  Statistical bibliography or bibliometrics , 1969 .

[27]  Peter Willett,et al.  Transitioning from a Conventional to a 'Mega' Journal: A Bibliometric Case Study of the Journal Medicine , 2017, Publ..

[28]  K. Behrns,et al.  Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways , 2008, Hepatology.

[29]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[30]  Jin Hyoung Kim,et al.  Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system. , 2015, World journal of gastroenterology.

[31]  David Victor,et al.  Hepatocellular carcinoma: a review , 2016, Journal of hepatocellular carcinoma.

[32]  Hideo Tanaka,et al.  Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures , 2011, Journal of epidemiology.

[33]  H. Johnsen,et al.  Cancer stem cell definitions and terminology: the devil is in the details , 2012, Nature Reviews Cancer.

[34]  D. Redden,et al.  A SEER Database Analysis of the Survival Advantage of Transarterial Chemoembolization for Hepatocellular Carcinoma: An Underutilized Therapy. , 2017, Journal of vascular and interventional radiology : JVIR.

[35]  Petra Koudelkova,et al.  Role of epithelial to mesenchymal transition in hepatocellular carcinoma. , 2016, Journal of hepatology.

[36]  Robert Dalpé,et al.  Bibliometric analysis of biotechnology , 2002, Scientometrics.

[37]  Ching-Lung Lai,et al.  Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region , 2016, Gut and liver.

[38]  J. Rowe,et al.  Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis , 2017, Journal of carcinogenesis.

[39]  Y. Menu Janus and the Great Men , 2017, European Radiology.

[40]  Grant Lewison,et al.  The State of Lung Cancer Research: A Global Analysis , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[41]  X. Wang,et al.  Clinical implications of cancer stem cell biology in hepatocellular carcinoma. , 2012, Seminars in oncology.

[42]  Y. Kim,et al.  Transarterial chemoembolization of hepatocellular carcinoma with segmental portal vein tumour thrombus , 2017, European Radiology.

[43]  Y. Cho,et al.  The most downloaded and most cited articles in radiology journals: a comparative bibliometric analysis , 2018, European Radiology.

[44]  J. Régis,et al.  Predictive Factors of Surgical Outcome in Frontal Lobe Epilepsy Explored with Stereoelectroencephalography , 2018, Neurosurgery.

[45]  Rodrigo Costas,et al.  The h-index: Advantages, limitations and its relation with other bibliometric indicators at the micro level , 2007, J. Informetrics.

[46]  H. El‐Serag,et al.  Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma , 2017, Cancer control : journal of the Moffitt Cancer Center.

[47]  H. El‐Serag,et al.  Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go? , 2014, Hepatology.